WallStSmart

HealthStream Inc (HSTM)vsVeeva Systems Inc Class A (VEEV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Veeva Systems Inc Class A generates 951% more annual revenue ($3.20B vs $304.06M). VEEV leads profitability with a 28.4% profit margin vs 6.0%. VEEV appears more attractively valued with a PEG of 0.86. VEEV earns a higher WallStSmart Score of 69/100 (B-).

HSTM

Hold

47

out of 100

Grade: D+

Growth: 4.0Profit: 4.0Value: 7.3Quality: 7.0
Piotroski: 4/9Altman Z: 2.56

VEEV

Strong Buy

69

out of 100

Grade: B-

Growth: 8.0Profit: 8.0Value: 9.3Quality: 7.8
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HSTMSignificantly Overvalued (-385.8%)

Margin of Safety

-385.8%

Fair Value

$4.15

Current Price

$20.97

$16.82 premium

UndervaluedFair: $4.15Overvalued
VEEVUndervalued (+25.9%)

Margin of Safety

+25.9%

Fair Value

$238.92

Current Price

$178.11

$60.81 discount

UndervaluedFair: $238.92Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HSTM2 strengths · Avg: 9.0/10
Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

VEEV6 strengths · Avg: 8.5/10
Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Profit MarginProfitability
28.4%9/10

Keeps 28 of every $100 in revenue as profit

PEG RatioValuation
0.868/10

Growing faster than its price suggests

Operating MarginProfitability
29.4%8/10

Strong operational efficiency at 29.4%

Revenue GrowthGrowth
16.0%8/10

16.0% revenue growth

EPS GrowthGrowth
23.2%8/10

Earnings expanding 23.2% YoY

Areas to Watch

HSTM4 concerns · Avg: 3.5/10
PEG RatioValuation
2.324/10

Expensive relative to growth rate

P/E RatioValuation
33.3x4/10

Premium valuation, high expectations priced in

Market CapQuality
$603.45M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
5.1%3/10

ROE of 5.1% — below average capital efficiency

VEEV1 concerns · Avg: 4.0/10
P/E RatioValuation
32.9x4/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : HSTM

The strongest argument for HSTM centers on Debt/Equity, Price/Book.

Bull Case : VEEV

The strongest argument for VEEV centers on Debt/Equity, Profit Margin, PEG Ratio. Profitability is solid with margins at 28.4% and operating margin at 29.4%. Revenue growth of 16.0% demonstrates continued momentum.

Bear Case : HSTM

The primary concerns for HSTM are PEG Ratio, P/E Ratio, Market Cap.

Bear Case : VEEV

The primary concerns for VEEV are P/E Ratio.

Key Dynamics to Monitor

HSTM profiles as a value stock while VEEV is a growth play — different risk/reward profiles.

VEEV carries more volatility with a beta of 1.12 — expect wider price swings.

VEEV is growing revenue faster at 16.0% — sustainability is the question.

VEEV generates stronger free cash flow (100M), providing more financial flexibility.

Bottom Line

VEEV scores higher overall (69/100 vs 47/100), backed by strong 28.4% margins and 16.0% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HealthStream Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HealthStream, Inc. provides provider and staff solutions for healthcare organizations in the United States. The company is headquartered in Nashville, Tennessee.

Visit Website →

Veeva Systems Inc Class A

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.

Visit Website →

Want to dig deeper into these stocks?